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Because of its relative simplicity and low complica-
tion and mortality rates, iliac angioplasty has become a
credible alternative to bypass surgery for the treatment
of short iliac occlusive lesions.1-5 Two-year patency
rates range from 75% to 95%.1,3,6,7 Among factors that
affect the outcome of the procedure, the radiological
aspect of the lesion plays a determining role. The
Society for Cardiovascular and Interventional Radiol-
ogy defined four categories of lesions based on the
length and the occlusive or stenotic character of the
lesion,8 with the worst results being observed in the
more severe lesions. Stenting has been advocated to
improve results of percutaneous transluminal angio-
plasty (PTA). However, evidence about whether a
stent should be inserted systematically or selectively is
lacking. In the absence of strong scientific data and for
economical reasons, we have chosen to insert a stent
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Purpose: The safety of iliac angioplasty and selective stenting performed in the operating
room by vascular surgeons was evaluated, and the short- and long-term results were
assessed by means of serial duplex scanning. 
Methods: Between 1989 and 1996, 281 iliac stenotic or occlusive lesions in 235 consec-
utive patients with chronic limb ischemia were treated by means of percutaneous trans-
luminal angioplasty (PTA) alone (n = 214) or PTA with stent (n = 67, 23.8%). There
were 260 primary lesions and 21 restenosis after a first PTA, which were analyzed sep-
arately. Stents were implanted in selected cases, either primarily in totally occluded arter-
ies or after suboptimum results of PTA (ie, residual stenosis or a dissection). Data were
collected prospectively and analyzed retrospectively. Results were reported in an inten-
tion-to-treat basis. Clinical results and patency were evaluated by means of symptom
assessment, ankle brachial pressure index, and duplex scanning at discharge and 1, 3, 6,
and every 12 months after angioplasty. To identify factors that may affect outcome, 12
clinical and radiological variables, including the four categories of lesions defined by the
Standards of Practice Committee of the Society of Cardiovascular and Interventional
Radiology, were analyzed separately. The statistical significances of life-table analysis of
patency were determined by means of the log-rank test. 
Results: There were no postoperative deaths or amputations. Local, general, and vascular
complications occurred in 2.1%, 1.3% and 4.7% of cases, respectively (total, 8.1%). The
mean follow-up period was 29.6 months. The cumulative patency rates ± SE of the 260
PTAs (including 55 PTAs plus stents) were 92.9% ± 1.5% at 1 month, 86.5% ± 1.7% at 1
year, 81.2% ± 2.3% at 2 years, 78.8% ± 2.9% at 3 years, and 75.4% ± 3.5% at 5 and 6 years.
The two-year patency rate of 21 redo PTAs (including 11 PTAs plus stents) was 79.1% ±
18.2%. Of 12 predictable variables studied in the first PTA group, only the category of
the lesion was predictive of long-term patency. The two-year patency rate was 84% ± 3%
for 199 category 1 lesions and 69.7% ± 6.5% for 61 category 2, 3, and 4 lesions togeth-
er (P = .02). There was no difference of patency in the stented and nonstented group.
Conclusion: Iliac PTA alone or with the use of a stent (in cases of occlusion and/or sub-
optimal results of PTA) offers an excellent long-term patency rate. Categorization of
lesions remains useful in predicting long-term outcome. PTA can be performed safely by
vascular surgeons in the operating room and should be considered to be the primary
treatment for localized iliac occlusive disease. (J Vasc Surg 1999;29:422-9.)
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selectively in those lesions reportedly prone to early
reocclusion1 (ie, PTA for totally occluded arteries and
suboptimal results after PTA, such as significant resid-
ual stenosis or dissection).
The surgical vascular community’s interest in
peripheral endovascular procedures is increasing. At
our institution, the vascular surgical team has been
involved in endovascular techniques since 1986. In
1994, we reported our experience of superficial
femoral artery angioplasty performed in the operat-
ing suite, with results comparable with those of
interventional radiologists.7 The present study was
undertaken (1) to evaluate prospectively the safety
of iliac angioplasty with selective stenting performed
in the operating room by vascular surgeons, (2) to
report the short- and long-term patency assessed by
means of duplex scanning, and (3) to determine fac-
tors that may affect long-term outcome.
PATIENTS AND METHODS 
Between January 1989 and February 1996, 281
consecutive iliac transluminal angioplasties were per-
formed in 235 patients. Angioplasty was done as a
first treatment in 260 lesions and as a redo proce-
dure in 21 lesions. Iliac PTA was used for about 40%
of the aortoiliac reconstructions performed for
occlusive diseases in our institution during the same
period. Forty-two of the patients were women, and
193 were men. The mean patient age was 58.2 ±
11.7 years (range, 37 to 91 years). Patient preoper-
ative risk factors are listed in Table I. Preoperative
symptoms evaluated from the history taken from the
patients were claudication (Fontaine stage II, with a
walking distance of less than 300 m) in 254 cases
(90.4%), rest pain (Fontaine stage III) in 11 cases
(3.9%), and gangrene or ulcer (Fontaine stage IV) in
11 (3.9%) cases. Four patients (1.4%) had an acute
ischemia, and one patient (0.4%) had blue toe syn-
drome. Patients with claudication were given a reha-
bilitation program, encouraged to stop smoking,
and given 250 mg/day of aspirin. PTA was per-
formed if claudication did not improve after three
months of this treatment. 
Selection of the lesions for percutaneous
transluminal angioplasty. All patients had under-
gone a duplex scan of the aorta and lower limbs. The
mean preoperative ankle brachial pressure index
(ABI) at rest was 0.74 ± 0.25. An arteriogram was
obtained in all patients, except eight patients in
whom a short stenosis of the iliac artery with a good
runoff and no contralateral disease was shown by
means of the duplex scan. In these eight cases,
angiography was performed as the first step of the
procedure. The choice to perform a PTA, rather
than a surgical procedure, was based on the type and
extent of the lesion. Unique short and tight (more
than 70%) stenotic or occlusive lesions of the com-
mon or external iliac artery were selected for PTA.
The mean lengths of stenoses and occlusions were
21.3 ± 14.1 mm and 61 ± 29 mm, respectively. The
maximum lengths of the stenoses and occlusions
were 70 mm and 90 mm, respectively. Multiple
stenoses, highly calcified circular lesions, and exten-
sive occlusions were treated surgically. Table II
shows the distribution and the types of the 281
lesions. Table III shows the distribution of the cate-
gories of the lesions, with redo lesions excluded, in
agreement with the Standards of Practice issued by
the Committee of the Society of Cardiovascular and
Interventional Radiology.8 Runoff was evaluated by
Table III. Distribution of 260 lesions treated with
primary percutaneous transluminal angioplasty
according to the Standards of Practice Committee
of the Society of Cardiovascular and Interventional
Radiology8
Category Definition Number (%)
1 Stenoses < 3 cm 199 (76.5)
2 Stenoses 3 to 5 cm 28 (10.8)
3 Stenoses > 5 cm and < 10 cm 20 (7.7)
or occlusion < 5 cm
4 Stenoses ‡ 10 cm or occlusions ‡ 5 cm 13 (5.0)
Table II. Distribution of 281 iliac lesions in 235
patients treated with transluminal angioplasty and
selective stenting. 
Artery Stenosis (> 70%) Occlusion
Common iliac 146 (51.9%) 13 (4.6%)
External iliac 111 (39.5%) 11 (3.9%)
Total 257 (91.5%) 24 (8.5%)
Table I. Risk factors in 235 patients treated with
transluminal iliac angioplasty and selective stenting 
Number %
Coronary heart disease 45 19.1
Diabetes mellitus 29 12.3
Hypertension 90 38.3
Hyperlipidemia 71 30.2
Renal insufficiency 12 5.1
Chronic obstructive pulmonary disease 26 11.1
Smoking 201 85.5
means of angiogram. It was defined as “good” when
both the superficial and deep femoral arteries were
patent with no stenosis greater than 50% and as
“poor” when one or two of these arteries, in most
cases the superficial femoral artery, had a stenosis
greater than 50% or was occluded. 
Procedures. All patients were treated in the oper-
ating room by vascular surgeons. In our department,
vascular surgeons and nurses working in the operating
room are well trained for endovascular techniques.
Anesthesiologists examined all patients preoperatively
and were available to perform a peridural anesthesia
whenever necessary (ie, for an expected long proce-
dure) or general anesthesia “on demand.” The collab-
oration with our radiologists was excellent, with a close
cooperation for the preoperative and postoperative
imaging and help in case of difficulty in catheteriza-
tion. Radiological equipment consisted of a Diasonics
2000 x-ray apparatus (Diasonics, Milpitas, Calif) with
a mobile C arm, video monitoring, and a computer-
ized system enabling digital imaging, road mapping,
and image archiving. Most endovascular procedures
were performed percutaneously (75%) under local
anesthesia (95%). Early in the series, when the ipsilat-
eral femoral pulse was not palpable or after failure of
the femoral artery puncture, a limited surgical
approach to the common femoral artery at the groin
was used. Later, as expertise increased, almost all cases
were performed percutaneously. In 10 cases, the con-
tralateral femoral artery was punctured and the
guidewire was pushed over the aortic bifurcation and
into the diseased artery (crossover technique). In two
cases, the axillary route was used because of a sharp
aortic bifurcation. In the presence of stenoses close to
the aortic bifurcation, a kissing balloon technique was
performed (four cases). Routinely, Benson guidewires
(Société Cook, Bagnolet, France) were used to cross
the lesions, except in the case of occlusions in which
Terumo guidewires (Terumo, St Quentin en Yvelines,
France) were used.
Low profile Meditech Ultra Thin balloon
catheters (Boston Scientific, Watertown, Mass) 2 to
4 cm in length and 7 to 12 mm in diameter were
used, according to the length of the lesion and size
of the artery as measured by means of intraoperative
angiograms. The balloons were dilated to a pressure
of 8 to 12 atm for 1 minute. After balloon angio-
plasty, a biplanar angiography was performed for
morphological assessment. The hemodynamic result
was assessed by means of a brachiofemoral pressure
measurement. No pharmacological test was per-
formed. In cases of residual stenosis, defined as 30%
or more reduction of luminal diameter of the treat-
ed artery in comparison with adjacent segments,
and/or in cases of brachiofemoral gradient of 10
mm Hg or more, balloon inflation was repeated. If
this second angioplasty resulted in a persistent steno-
sis according to the same criteria, a stent was insert-
ed. At the end of the procedure, the PTA with or
without stent was considered to be an early success
when there was no residual stenosis on both mor-
phological (less than 30% luminal narrowing) and
hemodynamic (femoral pressure at least equal to
brachial pressure) criteria. This protocol was applied
prospectively to all patients.
In eight cases, the iliac PTA was combined with
a surgical procedure in the same session: two femo-
rofemoral bypass grafts and one contralateral iliac
endarterectomy were performed to treat an occlud-
ed iliac artery, and two femoropopliteal bypass grafts
and three superficial femoral artery angioplasties
were performed to treat significant ipsilateral super-
ficial femoral artery lesions.
Stent placement. Stents were implanted in 67
lesions (23.8%). Forty-five lesions involved the com-
mon iliac artery, and 22 lesions involved the external
iliac artery. Stents were placed in the following indi-
cations: recanalization of a totally occluded artery (n
= 24); a residual stenosis after PTA alone, as previ-
ously defined (n = 24); a large dissection after bal-
loon dilatation (n = 7); or a restenotic lesion (n =
12). Stenting was performed in 35 (17%) category 1
lesions and in 32 (52%) category 2, 3, or 4 lesions.
There were 35 Strecker stents (Medi-Tech, Boston
Scientific, Watertown, Mass) implanted in the first
cases of the series, and 32 Palmaz stents (Cordis J
and J, Warren, NJ) were used in the later cases.
Single stents were used in 42 cases, and two or more
were used in 25 cases. We never implanted more
than three stents in the same site. 
During the procedure, 50 IU/kg of heparin
sodium was given intravenously. Postoperatively,
low–molecular-weight heparin was given for 24
hours (Dalteparine, Pharmacia S.A., Saint Quentin-
en-Yveline, France), and 250 mg/day lysin acetyl-
salicylate was given thereafter. In cases of intoler-
ance to aspirin, 250 mg/day ticlopidine hydrochlo-
ride was used.
Outcome evaluation and criteria. The surveil-
lance protocol of patency included a duplex scan
examination (Ultramark 4+, Advanced Technology
Laboratories, Bothell, Wash) before discharge and at
1, 3, 6, and every 12 months. All surviving patients
were seen at a consultation between Nov 1, 1995,
and Dec 31, 1996. During that visit, the patient’s
symptoms and clinical status were evaluated by the
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consulting surgeon. The aorta and iliac arteries and
the lower limb arteries were examined by means of
pulse-wave Doppler and ultrasonic duplex scan.9
These investigations were performed by an experi-
enced angiologist specially trained in duplex scan-
ning examination. Special emphasis was given to the
site of angioplasty, which was known by the angiol-
ogist, who had preoperative and perioperative
angiograms available. ABI was recorded, except in
patients with noncompressible arteries. Angiograms
were obtained whenever new symptoms developed,
when a 15% drop in ABI was detected, or a 50% or
more restenosis or occlusion was detected by means
of duplex scanning. 
All attempted iliac angioplasties during the study
period were included in this series. Cases in which the
guidewire could not cross the lesion or the artery
could not be dilated, with or without a stent, were
considered to be failures. In the remaining patients,
failures were defined as 50% or greater occlusion or
restenosis occurring distal, proximal, or at the site of
initial PTA. In patients who died before the final fol-
low-up examination or in patients lost to follow-up,
the patency was calculated according to the status of
their last follow-up examination.
Statistical analysis. Patient data, procedures,
immediate postoperative events, and results of fol-
low-up examinations were entered into a computer-
ized data-base system written specifically for this
purpose (J Meunier, Logit, Fontenay Sous Bois,
France). This data base allowed computation of life-
table analyses and other statistical evaluations,
including chi-square tests, t tests, and log-rank tests
with StatView 4.5 software (Abacus Concepts,
Berkeley, Calif). 
Cumulative patency rates for the entire series and
for each of the 12 variables listed in Table IV were
expressed by life-survival curve analysis, and patency
curves were compared by means of the log-rank test. 
RESULTS 
Three patients (1.1%) were lost to follow-up.
The median follow-up period was 29.6 months
(range, 1 month to 7 years).
Early results after primary and redo percuta-
neous transluminal angioplasty. There were no
deaths and no amputations in the first month. Three
patients sustained mild myocardial infarctions. Local
complications were five hematomas of the groin treat-
ed conservatively; all occurred in the nonstented
group. There were 11 vascular complications that
required surgical intervention: three lacerated femoral
arteries at the puncture site responsible for hema-
tomas; seven acute occlusions; and one rupture of the
iliac artery. The rupture occurred after an attempt to
dilate a 90%, 28 mm-long calcified stenosis of an exter-
nal iliac artery. The patient was immediately and suc-
cessfully converted to surgery. Local, general, and vas-
cular complications occurred in 2.1%, 1.3%, and 4.7%
of 235 patients, respectively (total, 8.1%).
Including the iliac rupture, 18 of 260 primary
PTAs (6.9%) were early failures. In four cases, the
lesion could not be crossed by the guidewire; in six
cases, protrusive and calcified stenoses could not be
crushed; and in seven cases, there was an immediate
thrombosis of the iliac artery. In 10 patients, surgery
Fig 1. Life-table curve of cumulative patency rates in 260 iliac primary percutaneous translu-
minal angioplasties for primary lesions.
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was performed immediately (iliofemoral bypass
grafting in four, femorofemoral bypass grafting in
six). The remaining eight patients were treated con-
servatively.
Three PTAs of the 21 lesions treated for resteno-
sis were early failures (14.3%). They all were treated
successfully by means of surgery.
There was no distal embolization.
The mean length of hospital stay for all patients,
including patients in whom a complication occurred,
was 3 ± 2.5 days. At the beginning of our experience,
we hospitalized patients for as long as five days. Later,
with increased experience and confidence, patients
entered the hospital the afternoon before PTA and
left the next morning, unless a complication occurred. 
LATE RESULTS
Overall clinical results. At the time of the final
follow-up examination, 23 patients (9.9%) had died,
most from coronary heart disease (52%). Two hun-
dred three patients (86.4%) were free of ischemic
symptoms in the limb. Twenty-six patients (11.1%)
had a claudication, three (1.2%) had rest pain, and
three had chronic ulcerative cutaneous lesions
(Table V). Mean ABI had increased from 0.74 ±
0.21 to 1.01 ± 0.21 (P < .05). These symptoms were
related to iliac restenosis in four cases and to outflow
impairment in 28 cases (15 superficial femoral artery
and 13 leg artery stenoses or occlusion). 
Two patients had undergone a thigh amputa-
tion. These two patients, who initially had a critical
ischemia, had been treated successfully for an occlu-
sion of the external iliac artery. Reocclusion hap-
pened four months later in one of these patients and
eight months later in the other. After attempts at
reconstructive surgery failed, above-the-knee ampu-
tations were required.
Patency after primary percutaneous translu-
minal angioplasty. During follow-up, there were
29 (11.1%) late failures. Symptoms developed in all
patients who had a failed procedure. Twenty-one
patients had a recurrence of claudication, six had rest
pain, and two had a necrotic lesion of the leg.
Twenty-two restenosis and seven reocclusions were
shown by means of duplex scanning and angiogra-
phy. The mean delay for late failure was 11 months.
Twenty-one patients (8.1%) were treated by redo
angioplasty; six had a bypass graft. Two patients with
mild claudication were treated conservatively.
The cumulative primary patency rates for the
260 primary PTAs are shown in Table IV and Fig 1.
Among the 12 variables listed in Table I that
were tested for their impact on long-term patency,
only the lesion category was significant. Category 1
lesions had a 14.3% higher patency rate at two years
than categories 2, 3, and 4 together (P = .020; Fig
2). When compared separately, the difference
between the four categories was statistically signifi-
cant (P = .025; Fig 3). However, because of the
small number of patients included in categories 3
and 4, the validity of this latter analysis should be
taken with some caution. 
Patency after redo percutaneous transluminal
angioplasty. Among the 21 restenotic lesions treat-
Table IV. Variables tested for outcome after 260 primary percutaneous transluminal angioplasties 
Variables Number* Two-year patency rate P
Male/Female 216/44 80.8/80.2 .60
Tobacco +/– 222/38 80.5/85.8 .68
Diabetes mellitus +/– 32/228 80.6/85.6 .56
Hypertension +/– 99/161 77.7/87.1 .20
Hyperlipidemia +/– 71/189 81.4/81.2 .91
Claudication/ischemia 232/28 82.4/69.4 .16
Occlusion/stenosis 24/236 77.4/81.7 .46
Common iliac/external iliac 148/112 83.0/78.0 .30
Category 1 lesions/category 2+3+4 199/61 84.8/69.6 .020
Category 1 lesion 212 89.5 .025
Category 2 lesion 33 78.7
Category 3 lesion 20 59.4
Category 4 lesion 13 65.6
Runoff good/poor 183/77 80.3/83.7 .61
Stent +/– 55/205 79.1/81.8 .83
Redo PTA +/– 21/260 78.9/81.3 .86
*Number of lesions at risk at the beginning of the study.
Category 1, Less than 3 cm stenoses; Category 2, 3 to 5 cm stenoses; Category 3, more than 5 cm but less than 10 cm stenoses, or less
than 5 cm occlusions; Category 4, More than 10 cm stenoses or more than 5 cm occlusions; PTA, percutaneous transluminal angioplasty.
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ed by redo PTA, there were three (14.3%) early fail-
ures and one late failure (at eight months). The two-
year patency rate was 79.1% ± 18.2%, which is not
statistically different from the two-year patency rate
of primary PTA (Table IV).
DISCUSSION 
Iliac PTA and stenting can be performed safely
and efficiently by vascular surgeons. Performing
PTA in the operating room offers advantages. When
the guide cannot cross the lesion, the balloon fails to
Fig 2. Life-table curves of cumulative patency rates of 199 category 1 (C1: stenoses less than
3 cm) lesions and of 61 category 2 (C2: 2 to 5 cm stenoses), category 3 (C3: 5 to 10 cm
stenoses, occlusions less than 5 cm), and category 4 (C4: stenoses more than 10 cm, occlu-
sions more than 5 cm) lesions treated by means of primary percutaneous transluminal angio-
plasty. Categories are defined from the Standards of Practice Committee of the Society of
Cardiovascular and Interventional Radiology. The difference calculated for the entire follow-
up period is statistically significant: P = .020.
Fig 3. Life-table curves of cumulative patency rates of 260 lesions treated by primary percu-
taneous transluminal angioplasty, according to the four categories of the Standards of Practice
Committee of the Society of Cardiovascular and Interventional Radiology. C1, Category 1
lesions; C2, category 2 lesions; C3, category 3 lesions; C4, category 4 lesions. The difference
calculated for the entire follow-up period is statistically significant: P = .025.
crush the plaque, or a complication occurs, the pro-
cedure can be immediately converted to surgery. In
this series, 10 failed angioplasties (3.6%) were
promptly managed surgically. Endovascular tech-
niques can be combined with classic surgery. In
patients with bilateral iliac disease, iliac PTA may be
used to improve inflow of a femorofemoral crossover
graft, which happened in two of our cases. In
patients with superficial femoral and iliac occlusive
disease, PTA and distal surgical reconstruction may
be done simultaneously, which occurred in two of
our patients. In addition, the practice of catheteriza-
tion and angioplasty improves a vascular surgeon’s
expertise in vascular diseases and ability to choose
the best treatment.
In the present series, the total rate of local, gen-
eral, and vascular complications was low (8.1%), and
there were no amputations nor deaths at 30 days,
which compares favorably with results in the litera-
ture.1,3,6,10 In the Johnston series, there was a 0.3%
death rate and a 7.9% complication rate.1 Murphy,
who used stents routinely, reported a 1.2% one-
month mortality rate and 9.7% complication rate.11
The most dramatic complication in the present series
was a rupture of the external iliac artery. This com-
plication was reported as the cause of one death in
Johnston’s series.1 This complication may occur with
heavily calcified lesions. Treating our patient in the
operating room probably avoided a deadly outcome.
In the present series, patency was assessed by
means of duplex scanning analysis. Angiography was
not performed systematically, because patients with-
out symptoms and with a normal duplex scan were
reluctant to have an invasive examination. Duplex
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scanning has previously been validated as a method
of detecting iliac stenoses and occlusions.9 In our
series, each time a restenosis or occlusion was detect-
ed by means of duplex scanning, the lesion was con-
firmed by means of arteriography. Analysis of symp-
toms or ABI measurements are not accurate means
of assessing patency. Restenosis or occlusion does
not always lead to new symptoms. New symptoms or
a drop in ABI are not specifically caused by the sole
evolution of the dilated iliac artery.
In the present study, the one- and five-year
patency rates, including early failures, were 86.6% ±
2.2% and 75.4% ± 3.5%, respectively. In the litera-
ture, patency rates of iliac PTA vary from study to
study. The analysis of a cohort of 2697 patients from
different series (not a meta-analysis) found five-year
patency rates ranging from 50% to 87% (mean,
72%).6 Our apparently more favorable results might
be explained by the recent character of our series,
the method of selecting patients, the use of modern
guidewires and low-profile balloons, and the use of
stents in lesions prone to reocclusion after PTA
alone. Most patients in the present study had claudi-
cation with short stenotic lesions and a good runoff,
which corresponds to type A grading of disease
severity for peripheral endovascular procedures
according to Ahn, Rutherford, and Becker et al,12
and 199 lesions were category 1 lesions, as defined
by the Standards of Practice Committee of the
Society of Cardiovascular and Interventional
Radiology.8 As a matter of fact, our best results were
obtained in this subgroup of patients (Fig 2).
Several factors may affect PTA outcome. By
means of the Cox proportional hazards regression
model, Johnston1 found that indication (claudica-
tion vs salvage), lesion site (common iliac vs other),
runoff (good vs poor), diabetes mellitus, and a pre-
PTA ABI ratio greater than 0.5 were associated with
success. In the subanalysis of external iliac stenosis,
Johnston also found a lower patency rate for women
than for men.1 We found no difference in patency
rates whether patients were male or female, had dia-
betes mellitus, hypertension, or hypercholes-
terolemia, or were smokers. In series with balloon
angioplasty alone, best results have been obtained in
stenosed, rather than occluded, arteries.1,6 In
Johnston’s series,1 the three-year patency rate was
61.2% for stenoses and 48% for occlusions. In the
present series, no such correlations were found. This
may be because of the use of stents in all cases of
occlusion; we observed a two-year patency rate of
77.4% in this subgroup of lesions. We found that the
only significant factor of outcome was the preopera-
Table V. Limb status before percutaneous translu-




Pre-PTA End of follow-up
Number % Number %
I 0 0 247 87.9
II 254 90.4 26 9.2
III 11 3.9 3 1.2
IV 11 3.9 3 1.2
Acute ischemia 5 1.8 0 0
or blue toe
syndrome
Amputation 0 0 2 0.7
ABI 0.74 ± 0.21 1.01 ± 0.21*
*P < .05.
PTA, Percutaneous transluminal angioplasty; ABI, ankle brachial
pressure index.
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tive category of the lesions. Category 1 lesions were
statistically correlated with higher patency rates than
category 2, 3, and 4 lesions. 
The placement of stents as a means of improving
the long-term results after iliac PTA is debatable. Iliac
stents are generally associated with excellent results.
Because of iliac high flow and large diameter of the
lumen, the incidence of stenotic intimal hyperplasia is
very low. In a multicenter trial of nearly 600 PTAs
with primary stenting, Palmaz reported a clinical suc-
cess rate of 68.6% at 43 months.13 In 103 patients
with iliac occlusion treated by means of angioplasty
and stenting, Verwerk reported patency rates of 87%
at one year, 83% at two years, and 78% at three
years.14 Blum, who inserted a stent in patients with
residual stenosis after PTA for iliac occlusion, report-
ed two- and four-year primary patency rates of 90%
and 86%, respectively.10 In our group of patients with
a stent, the two-year patency rate was 79.1%. Despite
these promising results with stents, systematic stent-
ing after iliac PTA may not be justified; stents are cost-
ly, short stenotic lesions respond well to PTA
alone,7,14 and a higher complication rate has been
reported.11 We have inserted stents in lesions prone
to failure after PTA alone, mainly occlusions and
residual stenosis or dissections. Our results with this
selective use of stents are similar to those of series with
systematic stenting.15 The prospective, randomized
study from Tetteroo et al comparing systematic pri-
mary stenting with selective stent placement did not
find any statistically significant difference.16 These
results also favor selective stenting.
It is not known whether long stenoses should be
stented primarily. In our series, PTA for stenoses
exceeding 3 cm had a poorer outcome, and system-
atic stenting may have improved their results. On
the other hand, in Sullivan’s series15 of 288 patients
treated with systematic stenting, the lesions that
required multiple stent placements were associated
with the poorest results.
In conclusion, iliac PTA and selective stenting
for occlusion and suboptimal results of PTA offers
excellent long-term results. Categorization of
lesions remains useful in predicting long-term out-
come. Vascular surgeons, alone or with the help of
radiologists, should be personally involved in the
technical realization of percutaneous procedures,
probably guaranteeing an optimal selection of cases
for percutaneous and open procedures.
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